论文部分内容阅读
双收杆菌活菌制剂(康力得),经制成口服液后,鲜随机选择的肝硬变和慢性肝炎轻度病人服用,而且进行对比观察,疗效较好。回对象和方法1.l一般情况112例中,男93例,女19例;年龄20~60岁,平均41.5岁。以第八届全国病毒性肝炎学术会议,病毒性肝炎防治方案(试行,1990年
Bifidobacterium viable preparation (Kangde), after the preparation of oral solution, fresh randomly selected cirrhosis of the liver and mild chronic hepatitis patients taking, and the comparative observation, the effect is better. Back to the object and method 1. l General 112 cases, 93 males and 19 females; aged 20 to 60 years, mean 41.5 years old. The Eighth National Viral Hepatitis Symposium, Viral Hepatitis Prevention and Control Program (Trial, 1990